Aimed at policy makers at country, regional and international levels, this document provides a practical guide to how changing public-private roles in the pharmaceutical sector may affect drug accessibility and rational use. It examines the government role in drug manufacture and the instruments governments can use to promote public health principles through the private sector. The document concludes with a framework for countries planning reform of public and private roles in the drug sector, and looks at the key elements to consider in designing a strategy, and how such a strategy can be monitored and evaluated.
Health Economics and Drugs, DAP series no 5. Geneva, World Health Organization